These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6730523)
21. [Clinical evaluation of urinary NMP22 (nuclear matrix protein 22) bladder chek in the detection of patients with bladder cancer]. Kitsukawa S; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T; Matsumoto T; Aizawa T; Noda K; Ito T Hinyokika Kiyo; 2006 Mar; 52(3):167-72. PubMed ID: 16617867 [TBL] [Abstract][Full Text] [Related]
22. [Bladder tumor antigen test versus urinary cytology in patients with bladder tumors]. Gregersen B; Mommsen S; Svanholm H Ugeskr Laeger; 1999 Apr; 161(14):2071-3. PubMed ID: 10354792 [TBL] [Abstract][Full Text] [Related]
23. [Significance of urinary nuclear matrix protein 22 in diagnosis of transitional cell carcinoma of urinary tract]. Shao Y; Zhuang J; Xu SX; Liu DY Ai Zheng; 2002 Sep; 21(9):1005-7. PubMed ID: 12508552 [TBL] [Abstract][Full Text] [Related]
24. [Urinary cytology of transitional-cell carcinoma]. Piazza G; Galia A; Cosentino A; Grasso G Pathologica; 1995 Apr; 87(2):146-7. PubMed ID: 8532407 [TBL] [Abstract][Full Text] [Related]
25. [Cytological examination of urinary sediment in the diagnosis of neoplasms of the urinary tract]. Symonowicz P; Szymańska K; Rojewska J; Musierowicz A Wiad Lek; 1987 Apr; 40(8):543-8. PubMed ID: 3310406 [No Abstract] [Full Text] [Related]
26. [Evaluation of usefulness of urinary nuclear matrix protein 22 (NMP22) in the detection of urothelial transitional cell carcinoma]. Miyoshi Y; Matsuzaki J; Miura T Hinyokika Kiyo; 2001 Jun; 47(6):379-83. PubMed ID: 11496392 [TBL] [Abstract][Full Text] [Related]
27. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. Halling KC; King W; Sokolova IA; Meyer RG; Burkhardt HM; Halling AC; Cheville JC; Sebo TJ; Ramakumar S; Stewart CS; Pankratz S; O'Kane DJ; Seelig SA; Lieber MM; Jenkins RB J Urol; 2000 Nov; 164(5):1768-75. PubMed ID: 11025767 [TBL] [Abstract][Full Text] [Related]
28. Urinary cytology changes in protease inhibitor induced urolithiasis. Hamm M; Wawroschek F; Rathert P J Urol; 2000 Apr; 163(4):1249-50. PubMed ID: 10737512 [No Abstract] [Full Text] [Related]
29. [Exfoliative cytology by the Sayk sediment chamber method]. Gorski J Z Urol Nephrol; 1981 Mar; 74(3):199-202. PubMed ID: 7223101 [TBL] [Abstract][Full Text] [Related]
30. [Fresh staining of urinary sediment with toluidine blue as a routine method for the screening of neoplasms of the urinary tract]. Piselli A; Placidi A Recenti Prog Med; 1982 Apr; 72(4):540-4. PubMed ID: 6183720 [No Abstract] [Full Text] [Related]
31. Analysis of atypical urine cytology in a tertiary care center. Deshpande V; McKee GT Cancer; 2005 Dec; 105(6):468-75. PubMed ID: 16080177 [TBL] [Abstract][Full Text] [Related]
32. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings. Bergman J; Reznichek RC; Rajfer J BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364 [TBL] [Abstract][Full Text] [Related]
33. [The value of urine sediment cytomorphology in the ambulatory differential diagnosis of hematuria]. Obroniecka I; Rojewska J; Wańkowicz Z Pol Merkur Lekarski; 1998 Nov; 5(29):285-7. PubMed ID: 10101502 [TBL] [Abstract][Full Text] [Related]
34. Urinary cytology as a screening study to detect urinary malignancies. Moffat NA Wis Med J; 1978 Apr; 77(4):S37-S38. PubMed ID: 645101 [No Abstract] [Full Text] [Related]
40. [Specificity and sensitivity of an immunologic test method for urologic neoplasms]. Günther M; Friedrich A; Seyfarth M; Jenssen HL; Köhler H; Werner H; Erdmann T Z Urol Nephrol; 1978 Oct; 71(10):741-2. PubMed ID: 735467 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]